StockSelector.com
  Research, Select, & Monitor Monday, June 18, 2018 11:09:58 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Arrowhead Pharmaceuticals, Inc.$13.73$2.6624.03%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Arrowhead Pharmaceuticals, Inc. has an overall rank of 6516 out of 7164 stocks based on 8 positive rankings and 9 negative rankings.

Positive Rankings
Historic Revenue Growth
Arrowhead Pharmaceuticals rank is 17
90 Day Gain
Arrowhead Pharmaceuticals rank is 154
Estimated Revenue Growth
Arrowhead Pharmaceuticals rank is 230
Debt-to-Equity
Arrowhead Pharmaceuticals rank is 651
Target Prices
The average analysts' target price is $11.50 for Arrowhead Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Arrowhead Pharmaceuticals is ranked 686.
Low Put/Call
Arrowhead Pharmaceuticals has a low Put/Call ratio of 0.29 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Arrowhead Pharmaceuticals is ranked 1309.
Highest Cash Growth
Arrowhead Pharmaceuticals rank is 1505
10 Day Gain
Arrowhead Pharmaceuticals rank is 2061
Negative Rankings
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Price-to-Sales
Arrowhead Pharmaceuticals rank is 204
Negative Stoch Cross
Arrowhead Pharmaceuticals rank is 248
Negative Net Margin
Arrowhead Pharmaceuticals rank is 368
Price-to-Book
Arrowhead Pharmaceuticals rank is 451
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Arrowhead Pharmaceuticals is ranked 541.
Negative ROE
Arrowhead Pharmaceuticals rank is 660
Negative ROA
Arrowhead Pharmaceuticals rank is 695
High vPut/Call
Arrowhead Pharmaceuticals has a high Put/Call ratio of 0.22 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Arrowhead Pharmaceuticals is ranked 995.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.